/Investor DB

LionBird — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Phantom Neurophantomneuro.comin𝕏Seed · Mar 2022 · $3M

Phantom Neuro develops neurotechnology for human-machine interaction, with a focus on applications for limb-loss and amputee populations.

AI & Machine LearningBiotechDeep TechMedical DevicesRoboticsAustin, US

Connor Glass(Executive Officer, Director, Promoter)in

BoardD.A. Wallach(Director)inEdward Michael(Director)in

Board seatRobert Lord· per SEC Form D

Co-investorsBreakout VenturesCapital FactoryCrosscourt VenturesDraper AssociatesGaingelsTime BioVentures+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Rhino Health

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.